AAPL337.00+4.59 (+1.38%) ▲|ABBV264.02+1.51 (+0.58%) ▲|ABT102.23-0.13 (-0.13%) ▼|ACN190.29+0.65 (+0.34%) ▲|ADBE252.67+2.17 (+0.87%) ▲|AMAT417.40+2.02 (+0.49%) ▲|AMD545.09+32.59 (+6.36%) ▲|AMGN379.78+3.43 (+0.91%) ▲|AMT175.58-0.81 (-0.46%) ▼|AMZN251.19+5.23 (+2.13%) ▲|AVGO347.30+7.79 (+2.29%) ▲|AXP311.17-1.26 (-0.40%) ▼|BA197.00-4.96 (-2.46%) ▼|BAC58.18+0.28 (+0.48%) ▲|BKNG170.52-0.88 (-0.51%) ▼|BLK1,053.96+16.72 (+1.61%) ▲|BMY62.84-0.76 (-1.20%) ▼|BNY153.02-0.45 (-0.29%) ▼|BRK-B509.20-10.60 (-2.04%) ▼|C132.70-0.25 (-0.19%) ▼|CAT798.57+15.85 (+2.03%) ▲|CL87.73+0.71 (+0.82%) ▲|CMCSA22.91-0.82 (-3.46%) ▼|COF202.04-1.15 (-0.57%) ▼|COP133.19+0.65 (+0.49%) ▲|COST893.93+0.19 (+0.02%) ▲|CRM242.85-7.25 (-2.90%) ▼|CSCO110.24+2.50 (+2.32%) ▲|CVS90.27-1.45 (-1.58%) ▼|CVX211.57+0.03 (+0.01%) ▲|DE685.63+16.16 (+2.41%) ▲|DHR212.50+4.14 (+1.99%) ▲|DIS105.35-1.64 (-1.53%) ▼|DUK118.54+0.78 (+0.66%) ▲|EMR147.40+1.57 (+1.08%) ▲|FDX305.88+4.16 (+1.38%) ▲|GD355.95-4.05 (-1.13%) ▼|GE313.47+0.57 (+0.18%) ▲|GEV924.93-0.16 (-0.02%) ▼|GILD150.89+3.21 (+2.17%) ▲|GM86.62+2.33 (+2.76%) ▲|GOOG343.68+4.32 (+1.27%) ▲|GOOGL347.33+4.46 (+1.30%) ▲|GS951.47+13.49 (+1.44%) ▲|HD302.51+0.04 (+0.01%) ▲|HON206.49-1.17 (-0.56%) ▼|IBM237.75+0.26 (+0.11%) ▲|INTC108.80+7.75 (+7.67%) ▲|INTU313.13-5.00 (-1.57%) ▼|ISRG383.54+1.25 (+0.33%) ▲|JNJ270.22+2.94 (+1.10%) ▲|JPM349.31+0.39 (+0.11%) ▲|KO88.06+0.19 (+0.22%) ▲|LIN458.48-3.61 (-0.78%) ▼|LLY1,152.44+14.62 (+1.28%) ▲|LMT538.09+0.84 (+0.16%) ▲|LOW194.19+0.09 (+0.05%) ▲|LRCX269.31+0.08 (+0.03%) ▲|MA565.73-2.02 (-0.36%) ▼|MCD248.48-0.08 (-0.03%) ▼|MDLZ62.04-0.32 (-0.51%) ▼|MDT92.77+0.17 (+0.18%) ▲|META682.31+9.00 (+1.34%) ▲|MMM164.71+2.06 (+1.27%) ▲|MO69.70-0.40 (-0.57%) ▼|MRK147.15+2.24 (+1.55%) ▲|MS203.52+1.10 (+0.54%) ▲|MSFT497.75+7.45 (+1.52%) ▲|MU977.50+50.95 (+5.50%) ▲|NEE81.28+0.91 (+1.13%) ▲|NFLX75.31-1.10 (-1.44%) ▼|NKE36.36+0.58 (+1.62%) ▲|NOW138.47-1.35 (-0.97%) ▼|NVDA219.34+5.44 (+2.54%) ▲|ORCL150.59+7.43 (+5.19%) ▲|PEP133.66-0.68 (-0.51%) ▼|PFE27.64+0.18 (+0.66%) ▲|PG147.55+0.53 (+0.36%) ▲|PLTR176.24+1.90 (+1.09%) ▲|PM190.48-1.23 (-0.64%) ▼|QCOM188.71+3.87 (+2.09%) ▲|RTX193.54-3.29 (-1.67%) ▼|SBUX96.67-0.67 (-0.69%) ▼|SCHW104.63-0.53 (-0.50%) ▼|SO86.76+0.53 (+0.61%) ▲|SPG204.47+1.53 (+0.75%) ▲|T25.39-0.47 (-1.82%) ▼|TMO658.32+9.89 (+1.53%) ▲|TMUS166.45-9.81 (-5.57%) ▼|TSLA366.20+8.12 (+2.27%) ▲|TXN258.14-2.53 (-0.97%) ▼|UBER70.87-0.10 (-0.14%) ▼|UNH375.21-0.05 (-0.01%) ▼|UNP282.48+1.56 (+0.56%) ▲|UPS100.17+1.40 (+1.42%) ▲|USB60.25+0.52 (+0.87%) ▲|V369.93-1.00 (-0.27%) ▼|VZ48.33-1.43 (-2.87%) ▼|WFC86.89-0.16 (-0.18%) ▼|WMT106.79-0.71 (-0.66%) ▼|XOM163.27-0.05 (-0.03%) ▼|AAPL337.00+4.59 (+1.38%) ▲|ABBV264.02+1.51 (+0.58%) ▲|ABT102.23-0.13 (-0.13%) ▼|ACN190.29+0.65 (+0.34%) ▲|ADBE252.67+2.17 (+0.87%) ▲|AMAT417.40+2.02 (+0.49%) ▲|AMD545.09+32.59 (+6.36%) ▲|AMGN379.78+3.43 (+0.91%) ▲|AMT175.58-0.81 (-0.46%) ▼|AMZN251.19+5.23 (+2.13%) ▲|AVGO347.30+7.79 (+2.29%) ▲|AXP311.17-1.26 (-0.40%) ▼|BA197.00-4.96 (-2.46%) ▼|BAC58.18+0.28 (+0.48%) ▲|BKNG170.52-0.88 (-0.51%) ▼|BLK1,053.96+16.72 (+1.61%) ▲|BMY62.84-0.76 (-1.20%) ▼|BNY153.02-0.45 (-0.29%) ▼|BRK-B509.20-10.60 (-2.04%) ▼|C132.70-0.25 (-0.19%) ▼|CAT798.57+15.85 (+2.03%) ▲|CL87.73+0.71 (+0.82%) ▲|CMCSA22.91-0.82 (-3.46%) ▼|COF202.04-1.15 (-0.57%) ▼|COP133.19+0.65 (+0.49%) ▲|COST893.93+0.19 (+0.02%) ▲|CRM242.85-7.25 (-2.90%) ▼|CSCO110.24+2.50 (+2.32%) ▲|CVS90.27-1.45 (-1.58%) ▼|CVX211.57+0.03 (+0.01%) ▲|DE685.63+16.16 (+2.41%) ▲|DHR212.50+4.14 (+1.99%) ▲|DIS105.35-1.64 (-1.53%) ▼|DUK118.54+0.78 (+0.66%) ▲|EMR147.40+1.57 (+1.08%) ▲|FDX305.88+4.16 (+1.38%) ▲|GD355.95-4.05 (-1.13%) ▼|GE313.47+0.57 (+0.18%) ▲|GEV924.93-0.16 (-0.02%) ▼|GILD150.89+3.21 (+2.17%) ▲|GM86.62+2.33 (+2.76%) ▲|GOOG343.68+4.32 (+1.27%) ▲|GOOGL347.33+4.46 (+1.30%) ▲|GS951.47+13.49 (+1.44%) ▲|HD302.51+0.04 (+0.01%) ▲|HON206.49-1.17 (-0.56%) ▼|IBM237.75+0.26 (+0.11%) ▲|INTC108.80+7.75 (+7.67%) ▲|INTU313.13-5.00 (-1.57%) ▼|ISRG383.54+1.25 (+0.33%) ▲|JNJ270.22+2.94 (+1.10%) ▲|JPM349.31+0.39 (+0.11%) ▲|KO88.06+0.19 (+0.22%) ▲|LIN458.48-3.61 (-0.78%) ▼|LLY1,152.44+14.62 (+1.28%) ▲|LMT538.09+0.84 (+0.16%) ▲|LOW194.19+0.09 (+0.05%) ▲|LRCX269.31+0.08 (+0.03%) ▲|MA565.73-2.02 (-0.36%) ▼|MCD248.48-0.08 (-0.03%) ▼|MDLZ62.04-0.32 (-0.51%) ▼|MDT92.77+0.17 (+0.18%) ▲|META682.31+9.00 (+1.34%) ▲|MMM164.71+2.06 (+1.27%) ▲|MO69.70-0.40 (-0.57%) ▼|MRK147.15+2.24 (+1.55%) ▲|MS203.52+1.10 (+0.54%) ▲|MSFT497.75+7.45 (+1.52%) ▲|MU977.50+50.95 (+5.50%) ▲|NEE81.28+0.91 (+1.13%) ▲|NFLX75.31-1.10 (-1.44%) ▼|NKE36.36+0.58 (+1.62%) ▲|NOW138.47-1.35 (-0.97%) ▼|NVDA219.34+5.44 (+2.54%) ▲|ORCL150.59+7.43 (+5.19%) ▲|PEP133.66-0.68 (-0.51%) ▼|PFE27.64+0.18 (+0.66%) ▲|PG147.55+0.53 (+0.36%) ▲|PLTR176.24+1.90 (+1.09%) ▲|PM190.48-1.23 (-0.64%) ▼|QCOM188.71+3.87 (+2.09%) ▲|RTX193.54-3.29 (-1.67%) ▼|SBUX96.67-0.67 (-0.69%) ▼|SCHW104.63-0.53 (-0.50%) ▼|SO86.76+0.53 (+0.61%) ▲|SPG204.47+1.53 (+0.75%) ▲|T25.39-0.47 (-1.82%) ▼|TMO658.32+9.89 (+1.53%) ▲|TMUS166.45-9.81 (-5.57%) ▼|TSLA366.20+8.12 (+2.27%) ▲|TXN258.14-2.53 (-0.97%) ▼|UBER70.87-0.10 (-0.14%) ▼|UNH375.21-0.05 (-0.01%) ▼|UNP282.48+1.56 (+0.56%) ▲|UPS100.17+1.40 (+1.42%) ▲|USB60.25+0.52 (+0.87%) ▲|V369.93-1.00 (-0.27%) ▼|VZ48.33-1.43 (-2.87%) ▼|WFC86.89-0.16 (-0.18%) ▼|WMT106.79-0.71 (-0.66%) ▼|XOM163.27-0.05 (-0.03%) ▼|
27.1 C
New York
Thursday, September 17, 2026

Tag: data

newssourceFORcompanyinformationcontent1releasesmarket

e-Bike Market Innovator Avinox Hosts Seven New Bike Partners at Eurobike 2025

Sixteen partners secured since the introduction of the Avinox Drive System at Eurobike 2024 FRANKFURT, Germany, June 25, 2025 /PRNewswire/ -- Avinox, the e-bike drive...

Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)

REYKJAVIK, ICELAND, PISCATAWAY, NEW JERSEY AND LONDON, UK (June 25, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv Biosciences LLC (“Kashiv”), a fully integrated biopharmaceutical company headquartered in New Jersey, US, and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK-headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines, today announced positive topline results from a confirmatory efficacy study comparing AVT23 (ADL-018), a proposed biosimilar to Xolair® (omalizumab), with the reference biologic.

Haal meer uit de cloud met expertise van AWS en een MSP

Amsterdam, Nederland, Juni 2025, Sean Tilley, Director of Sales EMEA bij 11:11 Systems, een provider van beheerde infrastructuuroplossingen, gaat dieper in op de basisinformatie van data voor de moderne onderneming en hoe die bedrijven in staat stelt te opereren. Naarmate de informatietechnologie blijft evolueren en steeds complexer wordt, moeten organisaties grotere hoeveelheden bedrijfskritieke gegevens opslaan en beheren. Bedrijven maken daarbij steeds vaker gebruik van cloud computing, waarbij vele ervoor kiezen om gebruik te maken van een van de openbare clouds, zoals AWS. Met Amazon S3, Amazon's objectopslagoplossing in de cloud, kunnen organisaties gegevens veilig in de cloud opslaan en ook snel op grote schaal ophalen, waardoor het  aantrekkelijk is voor bedrijven die innovatie willen bevorderen via cloud computing. 

e-Bike Market Innovator Avinox Hosts Seven New Bike Partners at Eurobike 2025

Sixteen partners secured since the introduction of the Avinox Drive System at Eurobike 2024 FRANKFURT, Germany, June 25, 2025 /PRNewswire/ -- Avinox, the e-bike drive system...

e-Bike Market Innovator Avinox Hosts Seven New Bike Partners at Eurobike 2025

Sixteen partners secured since the introduction of the Avinox Drive System at Eurobike 2024 FRANKFURT, Germany, June 25, 2025 /PRNewswire/ -- Avinox, the e-bike drive...

Amazon’s Largest Data Center: AI-Driven Infrastructure Expansion for Enhanced Computing Capacity

A transformation in data infrastructure is underway with Amazon's construction of a substantial data center network in New Carlisle, Indiana. This 1,200-acre development, which...

Hard Fork Interviews Sam Altman: Groundbreaking Revelations or Just More Tech Hype?

Sam Altman, the CEO of OpenAI, claims he’s had enlightening chats with President Trump about artificial intelligence. Yes, you read that correctly: Trump, the...

ECARX Secures Non-Automotive Customer for its Lidar Solution, Expanding into the High-Growth Robotics Market

Partnership with leading robotic lawn mower developer marks strategic diversification beyond automotive intelligence sector 
Partnership with leading robotic lawn mower developer marks strategic diversification beyond automotive intelligence sector

Nipocalimab showed greater sustained disease control versus approved FcRn blockers for generalised myasthenia gravis (gMG) at multiple timepoints over 24 weeks in newly published...

The ITC compared all published Phase 3 data of these treatments, leveraging longitudinal results, and findings reinforce the importance of consistent, sustained disease control in managing a chronic autoantibody disease like gMG

Blue Earth Therapeutics: SNMMI Presentation of Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial

−  Results show delivery of high radiation doses to tumours compared with normal organs.−  Observed normal organ absorbed dosimetry results may allow administration of...

Blue Earth Therapeutics: SNMMI Presentation of Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial

−  Results show delivery of high radiation doses to tumours compared with normal organs.−  Observed normal organ absorbed dosimetry results may allow administration of...

£7.5 million Longitude Prize on ALS launches

LONDON, June 25, 2025 /CNW/ -- The Longitude Prize on ALS, a £7.5 million global challenge prize, has launched to incentivise and reward cutting...

Automation Anywhere Collaborates with Akshaya Patra to Power its Mission of Providing 5 million Daily Meals with Smarter AI Logistics

Strategic partnership enables AI-powered automation to enhance operational excellence, streamline donor engagement, and optimise a nationally scaled school meal programme serving millions of children BENGALURU,...

NBPE – Transaction in Own Shares

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsData

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers